Histiocytic Sarcoma: Challenging Course, Dismal Outcome

Kim Francis Andersen1, Lene Dissing Sjö2, Peter Kampmann3

  • 1Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

Summary

Histiocytic sarcoma (HS) is a rare cancer. This case highlights the diagnostic challenges and aggressive nature of HS, emphasizing the need for effective treatment strategies.